Oct 23 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- NEGLIGIBLE COVID REVENUE IS EXPECTED IN FY24 RESULT
- Q1 VOLUME RESULTS IN UNDERLYING CORE BUSINESS SHOW VOLUME GROWTH OF 5% OVER PCP
- WORKFORCE AVAILABILITY AND ACCESS TO SERVICES AFFECTING HEALTHCARE SERVICE VOLUMES
- WILL ACHIEVE A SIMILAR EBIT RESULT IN FY24 OF BETWEEN A$65 MILLION AND A$70 MILLION
Oct 23 (Reuters) - Australian Clinical Labs Ltd (ACL) :...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.79 |
Change
-0.010(0.36%) |
Mkt cap ! $549.8M | |||
| Open | High | Low | Value | Volume |
| $2.79 | $2.80 | $2.78 | $78.91K | 28.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 64095 | $2.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.80 | 7112 | 10 |
View Market Depth
| Last trade - 10.29am 31/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |